Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Search for Market Research Reports:    

Russia Pharmaceuticals and Healthcare Report Q3 2007

Published by: Business Monitor International

Published: Dec. 13, 2007 - 65 Pages


Table of Contents


Executive Summary
Russia Pharmaceuticals & Healthcare Industry SWOT
Russia Political SWOT
Russia Economic SWOT
Russia Business Environment SWOT
Russia: Business Environment Ranking
Table: Central And Eastern Europe Business Environment Rankings
Business Environment Ranking
Economics - Long-Term Risk
Politics - Long-Term Risk
Regulatory Barriers
Domestic Sector Threat
Market Growth Potential
Russia: Market Summary
Regulatory Regime
Intellectual Property Environment
Pricing & Reimbursement Issues
Industry Developments
Industry Forecast Scenario
Overall Market Forecast
Table: Russia Drug Market Expenditure Forecasts
Key Growth Factors - Macroeconomic
Russia - Economic Activity
Prescription Market Forecast
Table: Russia Prescription Market Forecasts
OTC Market Forecast
Table: Russia OTC Market Forecasts
Generics Market Forecast
Table: Generics Market Forecasts
Table: Russia Pharmaceuticals Exports & Imports Forecasts
Other Healthcare Data Forecasts
Table: Russia Healthcare Data Forecasts
Key Risks To BMI’s Forecast Scenario
Competitive Landscape
Wholesale Sector
Retail Sector
Table: Pharmacies & Pharmacy Market Ratios
Company Monitors
Berlin-Chemie/Menarini Pharma GmbH
Gedeon Richter
Krka
Lek (Novartis/Sandoz)
Verofarm
BMI Forecast Modelling
How We Generate Our Industry Forecasts
Technical Process
Pharmaceutical Industry
Sources


Abstract

BMI has increased its forecast for Russia’s total pharmaceutical market value for 2007, raising it toUS$11.7bn, representing 20% year-on-year (y-o-y) growth. The five-year forecast for 2006 to 2011 sees10.9% average annual growth in dollar terms, with the market expected to reach a value of US$16.4bn.Still, compared to some local analysts, including RMBC, BMI’s estimates for this year are conservative.One reason for this is the year-on-year fall in spending in the DLO reimbursement programme followingmajor cuts in Q407 and significant arrears still owed to distributors. RMBC’s pharmacy market figuresfor H107 showed 24% y-o-y growth in ruble terms, with market value reaching US$3.89bn.


Get Full Details About This Report >>
US: 800.298.5699
Int'l: +1.240.747.3093
Buy this Report
Price and Delivery Options
Search Inside Report


 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

 

© MarketResearch.com 2008